Dipeptydil peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

Authors :: Domenico Cozzolino
Dario Giugliano
Maria Ida Maiorino
Paolo Chiodini
Katherine Esposito
Giuseppe Bellastella
Antonio Ceriello
Esposito, Katherine
Cozzolino, Domenico
Bellastella, Giuseppe
Maiorino, Mi
Chiodini, Paolo
Ceriello, A
Giugliano, Dario
Publication Year :: 2011
Abstract: Aim: We assessed the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors vildagliptin, sitagliptin, saxagliptin and alogliptin to reach the haemoglobin HbA1c target of

Tools